Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
4.500
+0.330 (7.91%)
At close: Jun 26, 2026, 4:00 PM EDT
4.410
-0.090 (-2.00%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Apyx Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Apyx Medical stock have an average target of 6.00, which predicts an increase of 33.33% from the current stock price of 4.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2026.
Analyst Ratings
The average analyst rating for Apyx Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $6 | Buy | Reiterates | $6 | +33.33% | May 8, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $6 | Buy | Reiterates | $6 | +33.33% | Apr 14, 2026 |
| BTIG | BTIG | Buy Upgrades $6 | Buy | Upgrades | $6 | +33.33% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
59.56M
from 52.84M
Increased by 12.72%
Revenue Next Year
65.76M
from 59.56M
Increased by 10.40%
EPS This Year
-0.28
from -0.27
EPS Next Year
-0.26
from -0.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 59.9M | 68.0M | |
| Avg | 59.6M | 65.8M | |
| Low | 59.3M | 63.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.4% | 14.2% | |
| Avg | 12.7% | 10.4% | |
| Low | 12.3% | 6.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.28 | -0.26 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.